Manipal Journal of Nursing and Health Sciences
Volume 8
Issue 1 MJNHS

Article 8

1-1-2022

Yoke between COVID-19 infection and cardiovascular diseases:
Evidence briefing from Indian studies
Melita Sheilini
MCON, Manipal, shyli.mel@manipal.edu

Follow this and additional works at: https://impressions.manipal.edu/mjnhs
Part of the Medical Sciences Commons, and the Nursing Commons

Recommended Citation
Sheilini, Melita (2022) "Yoke between COVID-19 infection and cardiovascular diseases: Evidence briefing
from Indian studies," Manipal Journal of Nursing and Health Sciences: Vol. 8: Iss. 1, .
DOI: https://doi.org/10.55889/2582-7979.1029
Available at: https://impressions.manipal.edu/mjnhs/vol8/iss1/8

This Review Article is brought to you for free and open access by the MAHE Journals at Impressions@MAHE. It has
been accepted for inclusion in Manipal Journal of Nursing and Health Sciences by an authorized editor of
Impressions@MAHE. For more information, please contact impressions@manipal.edu.

Sheilini M et al., COVID-19 infection and cardiovascular diseases: Evidence briefing

Review Article

Yoke between COVID-19 infection and cardiovascular
diseases: Evidence briefing from Indian studies
Melita Sheilini
Email: shyli.mel@manipal.edu

https://doi.org/10.55889/2582-7979.1029

Abstract
Globally, cardiovascular diseases (CVDs) are of major concern. The current pandemic situation of Coronavirus
Disease 19 (COVID-19) infection has further hiked the burden of cardiovascular problems. Since India has a large
number of cases with cardiovascular problems the interlink between the COVID-19 infection and CVDs has greatly
challenged the field of medicine. The interaction between the drugs used in the management of COVID infection
and cardiovascular problems is another major area of concern. With the variant nature of the Coronavirus, cases
have surged leading to increased mortality and one of the major causes for mortality is cardiovascular complications.
This article aims to reflect on the effect of cardiovascular morbidity on COVID-19 infection and the cardiovascular
outcome of COVID-19 positive patients in India. The relevant articles for the review were searched using the three
databases: CINHAL, Scopus, and PubMed and the search was limited to the studies conducted from January 2020 till
May 2021. The review highlighted that Diabetes and Hypertension were the most common comorbidity and were the
major contributing factors for the mortality among patients diagnosed with COVID-19 in India.
Keywords: cardiac arrest, cardiovascular disease, COVID-19, coronavirus, coronary artery disease, coronary infarction,
SARS-CoV-2.

Introduction
According to the Global Burden of Disease, nearly
a quarter (24.8 %) of all deaths in India is due to
cardiovascular diseases (CVDs) (Gunnal, Ojha, &
Singh, 2021). The most prevalent conditions in India
include ischemic heart disease, hypertensive heart
disease, and cerebrovascular disease. CVD is now a
leading cause of mortality in India and the constant
hike in the CVDs will continue to pose a significant
economic and social burden on the country (AbdulAziz, Desikan, Prabhakaran, & Schroeder, 2019). In this
current pandemic situation, curbing the incidences of
CVD is going to be a great turning point in reducing the
mortality among COVID positives.
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India is one among the worst Coronavirus Disease 19
(COVID-19) hit Asian nations claiming the lives of
133738 people who succumbed to death due to the
COVID infection by November 2020 (www.mohfw.
gov.in). One of the principal causes of mortality in
COVID-19 patients is Diabetes Mellitus. Associated
cardiovascular problems make them more vulnerable.
The Centre for Disease Prevention and Control (CDC)
recommends proper therapeutic management and
monitoring of blood glucose among diabetics (Goel &
Kumar, 2021).
Though COVID-19 infection affects mainly the
respiratory system, patients positive for COVID-19
are also presenting with features evocative of cardiac
problems such as chest pain and electrocardiographic
(ECG) changes. COVID-19 infection can cause
myocardial injury and the elevated Troponin may mimic
the diagnosis of Acute Coronary Syndrome (ACS). But
rapid detection of antibodies for COVID-19 can help
triage patients with symptoms of ACS and COVID
19(Bansal, 2020; Mahajan, Negi, Ganju, & Asotra,
2020).
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The surge in COVID-19 cases in India hampered the
regular follow-up of individuals with cardiovascular
problems resulting in people seeking health care services
only when the health condition gets deteriorated and
in need of emergency medical aid. The main reason
for this declined rate of people seeking healthcare
services is due to the unavailability of transportation
access and fear of catching COVID-19 in hospitals
which is evident with the positive trend in Acute
Coronary Syndrome paralleling the pandemic trend
(Ramakrishnan et al., 2020). When they come in such a
situation to the hospital, in the process of COVID-19
protocol management in the hospital, they become
the high-risk group for being tested positive for the
COVID-19 infection.
The current pandemic situation has brought few
changes in the treatment modality among cardiac
patients. Due to the risk of spreading infection
from the COVID-19 positive patients during the
cardiac intervention procedures; they are treated
conservatively with fibrinolytic therapy in the absence
of contraindications. If the fibrinolytic checklist does
not allow for the patient to go for non-interventional
reperfusion therapy, those patients are to be intubated
following all standard precautions and then perform
the cardiac interventional reperfusion procedures.
Coagulation parameters are deranged in COVID-19
patients, which requires diligent care and monitoring
of patients during thrombolytic therapy while
tracking the bleeding parameters of the patients
(Ramakrishnan et al., 2020; Guha et al., 2020).
The findings of electrocardiography of patients with
COVID-19 infection may show focal or diffuse STsegment depression or elevation even without coronary
artery disease (CAD). It is possible for supraventricular
arrhythmias to develop without CAD. The disease drug
interaction is also the reason for the arrhythmias among
COVID patients. To mention a few: QT prolongation
and Torsades de Pointes (TdP) is a concern among
patients treated with hydroxychloroquine and
azithromycin as combination drugs for the treatment
of COVID infection (Prasad et al., 2020). The other
antiviral drugs Lopinavir and Ritonavir also cause QT
prolongation and conduction disturbances and can

result in myopathy when co-administered with statins.
Whereas Ribavirin has variable effects on Warfarin
dosing. The diagnosed cardiac patients who are on Tab.
Amiodarone needs to be monitored carefully for the
QT prolongation since they can develop Amiodaroneinduced QT prolongation (Guha et al., 2020).
Globally, several studies are conducted to find out
the interaction of COVID-19 and the cardiovascular
effects. There is a steady increase in the rate of COVID
infection and mortality in India. A study from India
found that 78% of COVID-19 patients developed
heart diseases, independent of pre-existing conditions
(Kaul, 2020). Another review from India reported that
around 86% of the fatalities have been reported among
those with co-morbidities like diabetes, hypertension,
chronic kidney and heart-related issues (Srivastava,
2020). Given these alarming statistics of COVID-19
related cardiovascular problems, this review focuses
on the studies conducted in India highlighting the
interconnection between cardiovascular issues and the
COVID-19.
The search was limited to the studies conducted in
the last year (January 2020 till May 2021). The full-text
articles of Randomized Controlled Trials, Reviews,
Systematic reviews, and the studies conducted among
Indians including adult population above 19 years of
age were included in this review. In total, 54 studies in
PubMed, 37 studies in CINAHL, and 197 studies in
Scopus were retrieved in the final search. Out of those
nine studies were found to be inclusive of the review as
per the inclusion criteria.
The following table outlines the nine Indian studies
describing the presenting complaints, comorbidities
and the outcome among the COVID-19 confirmed
inpatients. (Table 1).

Discussion
The review found that many of the patients diagnosed
with COVID-19 in India were known Diabetics
and Hypertensives. Some cases developed cardiac
complications after being positive for COVID-19
and the mortality was high among patients with
comorbidities mainly DM and HTN. The diagnosed
cases suffered from a new diagnosis of cardiac muscle
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Case series

Design
N=27

Sample

(Bhandari,
al., 2020)

4

et SMS Medical
College and
attached
hospitals,
Jaipur, India

(Laxminarayan, Andhra Pradesh
et al., 2020)
and Tamil Nadu
states, India

3

Survey and
follow up

Survey
including
contact
tracing and
testing.

N=522

N=33,584

Tertiary
care Retrospective N=108
hospital, India
observational
study

ICU of V.M.M.C
and Safdarjung
Hospital,
India.

(Kunal, et al.,
2020)

(Pande,
Kochhar, Saini,
Ganapathy, &
Gogia, 2020)

The setting of the
study

2

1

Author and
Year

Fever (75.9%)
Cough (55.6%)
Dyspnea (52.8%)
Chest pain (8.3%)
Sinus tachycardia (0.9%)
First degree AV Block (4.6%)
VT/ VF (1.8%)
Sinus Bradycardia (0.9%)
QT prolongation (17.6%)

Fever (77.7%)
Shortness of breath (70.3%)
Cough (62.9%)
Haemoglobin (<7g/dl) (11.11%)
Lymphocytopenia (7.4%)
Thrombocytopenia and Thrombocytosis
(3.7% each)
Elevated serum bilirubin (3.7%)
Elevated liver enzymes (22.2%)
No coagulopathy
Elevated lactate (25.9%)
Elevated creatinine (18.5%)
Chest X-Ray - Bilateral lung infiltrates (88.8%)
Mild, Moderate and Severe Hypoxemia
(n=3,8,16 respectively).

•
•
•
•
•
•
•

Fever (55.9%)
Cough (52.75%)
Sore throat (49.6%)
Shortness of breath (46.45%)
Headache (26.77%)
Chest pain (6.29%)
Pain abdomen, fatigue, joint pain, altered
sensorium (7.87%).

Not assessed

•
•
•
•
•
•
•
•
•

•
•
•
•
•
•
•

•
•
•
•
•
•

Presenting symptoms and baseline investigation
findings of the COVID positive patients

HTN (38%)
DM (32.4%)

•
•
•

•
•
•

HTN (42.46%)
DM (39.72%)
COPD/Bronchial
Asthma (16.43%)
CAD (13.69%)
CKD (13.69%)
Valvular Heart
Disease (6.84%).

Comorbidities among
the total population are
not mentioned in the
article.

•
•

• DM (43.7%)
• HTN (37.5%)
• Both DM and HTN
(18.7%).

Associated
Comorbidities

Study Findings

Table 1
Indian Studies Reporting the Presenting Complaints, Comorbidities and the Outcomes among the COVID-19 confirmed.

•
•

Mortality (2.87%)
All deceased had
multiple comorbid
conditions.

Among 280 decedents
in two Indian states, the
most prevalent premorbid
conditions were:
•
DM (53.2%)
•
Sustained HTN (51.8%)
•
CAD (13.6%)
•
Renal disease (10.4%).

The cardiovascular
complications reported
were:
•
Acute cardiac injury
(25.9%)
•
Heart failure,
Cardiogenic shock, and
ACS (3.7% each)

• Managed with oxygen
therapy (37%)
• Required ventilator
support (62.9%)
• Developed Shock and
MODS (25.9%)
• ICU mortality rate
(59.2%).

The outcome of the
patients
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(Shukla,
Chavali, Mukta,
Mapari, & Vyas,
2020)

(Anudeep,
Somu, &
Kumar, 2020)

(Kayina, et al.,
2020)

7

8

9
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Sample

Prospective
N=235
observational
study.

Retrospective N=50
observational
study.

Single-center, N=24
retrospective
observational
study.

Retrospective N=21
observational
case series.

Retrospective N=176
study with
descriptive
research
design.

Design

Fever (68.1%)
Cough (59.6%)
Shortness of breath (71.9%)
Gastrointestinal symptoms (12.3%)
Non ST Elevation Myocardial Infarction
(0.85%)
• Bilateral (80.5%) and unilateral (8.8%)
infiltrations in Chest X-Ray.
• Acute ischemic stroke (2.13%).

•
•
•
•
•

• Cough and dyspnoea (84%)
• Fever (70%)
• New-onset ECG abnormalities (24% with
Sinus bradycardia (4%), AVNRT (4%), ST-T
changes (8%), PR prolongation (8%).

• Cough and tachypnea (100%).
• Bilateral (87.5%) and Unilateral (12.5%)
pulmonary infiltration in Chest X-Ray.

9 patients were symptomatic. Out of them:
•
Cough and Fever (23.8%)
•
Sore throat (4.8%)
Breathlessness and headache (13.6%).

DM (27.8%)
HTN (22.1%)
Both DM &
HTN (13%)

Associated
Comorbidities

Among the deceased:
• Respiratory problems
(13.6%)
• Cardiac ailments (6.2%)
• DM, HTN & CVD (2.8%)
• Kidney ailments (2.27%)
• Liver ailments (2.8%).

The outcome of the
patients

•
•
•
•
•

•
•

HTN- (28.1%)
DM- (23.3%)
CKD- (9.5%)
CLD- (4.3%)
Malignancy- (11%).

DM (64%)
HTN (44%).

DM & HTN (37.5%)

• Mortality within 24 hours
of ICU admission-(8.5%)
• Death due to AMI
with cardiogenic shock
(0.43%).
• Death due to refractory
hypoxia (9.79%).

• Mortality rate (38%)
• Smokers and
hypertensives
contributed to the
higher proportion of
nonsurvivors.

•
Mortality (16.66%)
• Pre-existing HTN (4.16%)
• All four have died due
to the development of
sepsis and multi-organ
dysfunction.

No mortality was reported.
• HTN (23.8%)
• DM (14.2%)
• Bilateral consolidation
of lower lobes of lungs
in Chest X-Ray (4.76%)
• Leukopenia (4.76%)

•
• Predominant symptoms- Fever and cough.
• Other symptoms-chest tightness, fatigue, and •
dyspnoea, diarrhoea, myalgia, and anorexia. •

Presenting symptoms and baseline investigation
findings of the COVID positive patients

Study Findings

Note. DM = Diabetes Mellitus; HTN = Hypertension; MODS = Multiple Organ Dysfunction Syndrome; AV Block = Atrio-Ventricular Block; VT = Ventricular Tachycardia;
VF = Ventricular Fibrillation; ACS = Acute Coronary Syndrome; CKD = Chronic Kidney Disease; CVD = Cardiovascular Disease; CLD = Chronic Liver Disease; AMI = Acute
Myocardial Infarction.

Tertiary care
hospital, New
Delhi, India.

Tertiary care
hospital, India.

Tertiary care
centre in Pune,
Maharashtra,
India.

Gupta, et al., Safdarjung
2020
tertiary care
hospital, New
Delhi, India.

6

Research report
with the search
using www.
covid19india.org.

(Majeed,
Ajmera, &
Goyal, 2020)

The setting of the
study

5

Author and
Year

Table 1 Cont...
Indian Studies Reporting the Presenting Complaints, Comorbidities and the Outcomes among the COVID-19 confirmed.
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injury especially myocardial infarction, myocarditis,
and cardiogenic shock. Most of the deaths were due
to refractory hypoxemia and multiorgan dysfunction
syndrome with cardiac complications being one of the
indicators for mortality.
The findings of this review are supported by studies
conducted in other countries. The results of a metaanalysis of observational studies revealed that the preexisting cardiovascular comorbidities or risk factors
were significantly associated with cardiovascular
complications in COVID-19 patients (Sabatino, Rosa,
Salvo, & Indolfi, 2020). Another systematic review
and meta-analysis revealed that hypertension was
the most common pre-existing comorbidity with a
frequency of 29.2%, followed by diabetes mellitus
(13.5%). The diseased group had higher cardiac and
inflammatory biomarkers compared with survivors
(Momtazmanes et al., 2020). Yet another systematic
review and meta-analysis showed that the relative
risk of developing severe COVID-19 or death was
significantly higher in patients with risk factors for
CVD (HTN and DM) (Bae, Kim, Kim, Shim, & Park,
2021). A retrospective cohort study conducted among
hospitalized COVID-19 positive adult patients revealed
that DM increased the risk of death from COVID-19
(Rastad, et al., 2020). A study conducted in China
revealed that DM and HTN were two of the major risk
factors for reaching the composite endpoints among
COVID-19 positive patients (Guan et al., 2020).
The review emphasizes on the role of nurses in
sensitizing the patients about the risk of cardiovascular
diseases linked with COVID infection.This can be an
added social responsibility of the nurses which can
help prevent the surge in patients getting hospitalized
due to COVID related complications and decrease
cardiovascular morbidity and mortality.

Conclusion
The COVID-19 pandemic has hit the routine health
review process of the patients due to the extended
lockdown imposed by the Government. This could
be one of the reasons for the increased cardiovascular
mortality among COVID infected with known cardiac
problems with loss to routine follow-up. Overall,

68

the findings of the review highlight that there is
strong bondage between COVID infection and
cardiovascular diseases. This reminds every individual
of the importance of self-responsibility and adherence
to the preventive measures for fighting COVID
infection and thereby contributing to the reduction in
cardiovascular-related morbidity and mortality due to
COVID infection in the country. It further emphasizes
the need for an early health-seeking behaviour among
symptomatic patients which can be the cornerstone in
the early prevention of morbidity and mortality among
patients with or without comorbidities.
Source of support: Nil.
Conflict of interest: Nil.
Source of support in the form of grants: Nil.
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